Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricPFEPfizerBMYBristol Myers SquibbMRKMerck & Co.
Snapshot
Price$24.04$55.00$120.60
Market cap$140.89B$113.40B$295.39B
Valuation
P/E18.8x19x33x
Forward P/E19.8x15.1x47.1x
Growth
Revenue growth1.4%1.8%2.9%
EPS growth-5.3%26.3%-48.3%
Profitability
Net margin11.8%12.3%13.6%
ROE8.4%41.6%17.9%
Balance sheet & cash
Debt / equity0.75x2.44x0.94x
Free cash flow yield11.2%15.4%2.9%
Dividend yield6.6%4.5%3.0%
Verdict
Investment ratingNeutral· 48Favorable· 60Weak· 40

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearPFEtoday $24BMYtoday $55MRKtoday $121
2027$18.39 – $26.97+12% CAGR$52.09 – $76.39+39% CAGR$92.26 – $135.31+12% CAGR
2028$18.76 – $27.51+7% CAGR$65.77 – $96.46+32% CAGR$94.10 – $138.02+7% CAGR
2029$19.13 – $28.06+5% CAGR$83.05 – $121.80+30% CAGR$95.99 – $140.78+5% CAGR
2030$19.52 – $28.62+4% CAGR$104.86 – $153.80+29% CAGR$97.91 – $143.60+4% CAGR
2031$19.91 – $29.20+4% CAGR$132.41 – $194.20+29% CAGR$99.86 – $146.47+4% CAGR
5-yr CAGR-3.7% – 4.0%19.2% – 28.7%-3.7% – 4.0%